Enanta Pharmaceuticals (ENTA) Net Cash Flow (QoQ) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -148.82% |
| Dec 31, 2025 | 141.07% |
| Sep 30, 2025 | 18.75% |
| Jun 30, 2025 | 37.76% |
| Mar 31, 2025 | -152.52% |
| Dec 31, 2024 | 3,131.55% |
| Sep 30, 2024 | 105.25% |
| Jun 30, 2024 | -217.61% |
| Mar 31, 2024 | 151.94% |
| Dec 31, 2023 | -364.35% |
| Sep 30, 2023 | -144.50% |
| Jun 30, 2023 | -28.93% |
| Mar 31, 2023 | 1,847.88% |
| Dec 31, 2022 | -111.33% |
| Sep 30, 2022 | 268.72% |
| Jun 30, 2022 | 84.05% |
| Mar 31, 2022 | -238.74% |
| Dec 31, 2021 | -20.42% |
| Sep 30, 2021 | 172.53% |
| Jun 30, 2021 | -429.20% |
| Mar 31, 2021 | 168.77% |
| Dec 31, 2020 | -151.78% |
| Sep 30, 2020 | -149.86% |
| Jun 30, 2020 | -45.45% |
| Mar 31, 2020 | 297.62% |
| Dec 31, 2019 | 44.92% |
| Sep 30, 2019 | -263.46% |
| Jun 30, 2019 | -137.34% |
| Mar 31, 2019 | 202.64% |
| Dec 31, 2018 | -51.16% |
| Sep 30, 2018 | 187.63% |
| Jun 30, 2018 | -2,069.39% |
| Mar 31, 2018 | -147.39% |
| Dec 31, 2017 | -94.52% |
| Sep 30, 2017 | 1,322.41% |
| Jun 30, 2017 | 316.92% |
| Mar 31, 2017 | -134.82% |
| Dec 31, 2016 | 149.21% |
| Sep 30, 2016 | 73.99% |
| Jun 30, 2016 | -411.75% |
| Mar 31, 2016 | -58.68% |
| Dec 31, 2015 | 1,202.18% |
| Sep 30, 2015 | 131.86% |
| Jun 30, 2015 | 29.50% |
| Mar 31, 2015 | -344.21% |
| Dec 31, 2014 | -20.67% |
| Sep 30, 2014 | -47.72% |
| Jun 30, 2014 | -39.50% |
| Mar 31, 2014 | 408.48% |
| Dec 31, 2013 | 55.75% |
| Sep 30, 2013 | 81.98% |
| Jun 30, 2013 | -203.46% |
| Mar 31, 2013 | 425.52% |
| Dec 31, 2012 | 56.09% |
| Sep 30, 2012 | 139.13% |